Barclays »

Recro Pharma shares owned by Barclays

Quarter-by-quarter ownership of Recro Pharma (SCTL) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Recro Pharma

Tip: Access up to 7 years of quarterly data

All positions including Recro Pharma held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recro Pharma by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $0 113 0.00
2021-09-30 $5.0k 2.6k 1.92
2021-06-30 $11k 4.7k 2.31
2021-03-31 $46k 16k 2.84
2020-12-31 $18k 6.3k 2.88
2020-09-30 $18k 8.9k 2.02
2020-06-30 $48k 11k 4.50
2020-03-31 $62k 7.4k 8.31
2019-12-31 $484k 26k 18.34
2019-09-30 $199k 18k 11.08
2019-06-30 $193k 19k 10.19
2019-03-31 $314k 54k 5.86
2018-12-31 $6.0k 794 7.56
2018-09-30 $52k 7.3k 7.16
2018-06-30 $12k 2.2k 5.48
2018-03-31 $56k 5.0k 11.32
2017-12-31 $24k 2.6k 9.20
2017-09-30 $5.0k 590 8.47
2017-06-30 $0 2.1k 0.00
2017-03-31 $117k 13k 8.73
2016-12-31 $18k 2.3k 7.90